首页 | 本学科首页   官方微博 | 高级检索  
     


Nanomedicines in the treatment of chronic hepatitis C--focus on pegylated interferon alpha-2a
Authors:Thomas Thea  Foster Graham
Affiliation:University College London Hospital NHS Trust, London.
Abstract:Nanotechnology is the application of nanotechnology within medicine. An illustration of this is the use of pegylation as a means of modifying naturally occurring proteins which may have clinical applications, in order to improve the pharmacodynamics of the protein resulting in an effective medication. An example of this is pegylated interferon. The purpose of this review is to examine the chemistry, clinical pharmacology, pharmacokinetics, pharmacodynamics, and clinical studies with 40 kDa pegylated interferon to illustrate the general principles of pegylated biological proteins. The use in clinical practice is reviewed along with the evidence for both efficiacy, safety, and advantages over standard interferon.
Keywords:nanomedicines   nanotechnology   pegylation   pegylated interferon   40 kDa pegylated interferon alpha-2a   hepatitis C
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号